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Background: Several general diseases cause blindness in patients with simultaneous combined retinal artery and
vein occlusion.
Methods/patients: We examined 14 patients with acute unilateral visual loss due to combined retinal artery and
venous occlusions. All 14 patients presented at the Polyclinic over a period of about 3 years. Fluorescein
angiography was carried out in 12 patients to confirm the diagnosis. Ten patients underwent Doppler sonography
and 11 echocardiography.
Results: Concerning systemic diseases, 11 of our 14 patients presented several cardiovascular risk factors, i.e.,
immunocytoma and arterial hypertension and hypercholesterolemia in one patient; another patient had chronic
bronchitis, tachycardia and hypercholesterolemia. Six patients presented coagulation anomalies, and eight patients
had arterial hypertension.
Doppler sonography revealed normal carotid arteries in nine of ten patients. In 8 of 11 patients, echocardiography
displayed no cardiac abnormalities.
Ophthalmoscopy revealed no emboli in any of these patients.
Conclusion: Unilateral simultaneous combined incomplete retinal artery and venous occlusions should be
considered as one entity. Eleven of our patients presented comorbidities reflecting several cardiovascular risk
factors. Immunological diseases, malignancies and coagulopathies can cause this ocular disorder, resulting in
blindness. No emboli were found in any of these patients. Patients suffering from acute visual loss must be
examined for the presence of systemic diseases to enable therapy at an early stage.Background
Systemic diseases in noninflammatory isolated branch or
central retinal artery occlusions or isolated branch or
central retinal vein occlusions have been described in
large patient cohorts by several authors [1-3]. Regarding
the rare entity of combined retinal artery and venous oc-
clusions, cardiovascular risk factors have generally been
documented in case reports involving few patients in
most publications [4-50].
Three different types of combined retinal artery and
vein occlusions (often incomplete) have been reported:
1. Central retinal vein occlusion (CRVO) with central
retinal artery occlusion (CRAO).Correspondence: Dieter.Schmidt@uniklinik-freiburg.de
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reproduction in any medium, provided the or2. CRVO with branch retinal artery occlusion
(BRAO).
3. CRVO with cilioretinal artery occlusion
(CLRAO).
Criteria for the entity of combined retinal artery
and venous occlusion are acute unilateral visual loss
with retinal edema (retinal whitening of the posterior
pole or along an artery), with or without a cherry red
spot on the macula, retinal hemorrhages, enlarged,
tortuous veins, delayed arterial dye filling of arteries
and prolonged arteriovenous transit time in fluores-
cein angiography. Complete occlusions of the central
retinal vein and central retinal artery are extremely
rare. Several publications have reported central retinal
vein occlusion in association with cilioretinal artery
occlusion [7,22,23,29-32,41,42,48]. Hayreh et al. [22]This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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artery occlusion results in a marked rise in intralu-
minal pressure in the capillary bed. Cilioretinal artery
occlusion is a hemodynamic block, not caused by
emboli.
McLeod [31] pointed out that the probability of
cilioretinal infarction increases with the increasing seve-
rity of CRVO. Pathogenesis of the combined CRVO with
CLRAO is regarded as a particular entity that differs
from the pathogenesis of combined central retinal artery
obstruction and central retinal vein occlusion.
The choroidal arterial steal mechanism can in-
fluence the development of combined CRV and CRA
occlusions.
Unilateral combined occlusion of the central retinal ar-
tery (CRAO) and central retinal vein (CRVO) was first
described by Gross in 1907 [18] in a 48-year-old woman
with anemia. Different causes of combined central re-
tinal artery and vein occlusion have been reported. We
propose various explanations for the disease’s develop-
ment in our 14 patients.Table 1 Case histories of ten patients with combined CRVO a
Age of patients Diagnoses of systemic dis
1. A 75-year-old male Immunocytoma (Waldenstr
hypercholesterolemia, adipo
2. A 61-year-old male Pulmonary emphysema, co
heart-echo: normal Dopple
3. A 70-year-old woman Arterial hypertension (200/1
sonography: normal carotid
4. A 62-year-old male Slightly increased blood pre
Doppler sonography: norm
5. A 36-year-old woman Raynaud’s disease; autoimm
tendency for arterial hypote
normal findings Doppler so
6. A 68-year-old male Metastatic prostate carcinom
anemia (hemoglobin. 6.7 g/
echo: normal findings Dopp
7. A 53-year-old male Hyperhomocysteinemia, hy
Parkinson’s disease, tenden
8. A 72-year-old woman Bronchopneumonia, leukoc
sized carotid stenoses
9. A 68-year-old male Heterozygote factor-V muta
hypertension, small colon c
10. A 57-year-old woman Factor V Leiden mutation (h
thrombosis of the lower rig
Mean age was of the 4 women and 6 men





disturbance: patient 7: 1 pa
Doppler sonography: nor
(no. 8) had bilateral medium
Abbreviations: CRVO central retinal vein occlusion, CRAO central retinal artery occlu
eye, LE left eye, Heart echo echocardiography, NLP no light perception.Case presentation
Methods and patients
The 14 patients (5 female and 9 male) had a mean age
of 57.6 years (33–75). All were examined at the Poly-
clinic of the University Eye Hospital over a period of ap-
proximately 3 years. The right eye was affected in nine,
the left eye in five patients. The patients were referred
because of acute unilateral visual loss.
Unilateral combined retinal artery and vein occlusions
were observed in all our patients. Ten (Table 1) pre-
sented combined CRVO and CRAO, and three patients
had combined CRVO and BRAO (Table 2). One patient
showed a combined cilioretinal artery occlusion (CLRAO)
and CRVO Figures 1, 2, 3, 4, 5, 6.
Etiologies
Diagnoses of ocular and systemic diseases (including pa-
tients with cilioretinal artery occlusion and CRVO)
Ocular diseases
Posterior scleritis: (Shukla et al. [43]), blunt ocular trau-
ma (Noble & Alvarez [34]), vitrectomy (Verma et al., [50]).nd CRAO
eases (number of patients)
öm’s disease); arterial hypertension (200/130 mmHg);
sity
r pulmonale, tachycardia; + chronic bronchitis; hypercholesterolemia
r sonography: normal carotid arteries
00 mmHg); hypercholesterolemia, heart-echo: normal findings Doppler
arteries
ssure, slightly increased homocysteine, heart-echo: normal findings
al findings in carotid arteries
une disease with evidence of serum antimitochondrial antibodies,
nsion with occasional low blood pressure (90/60 mmHg); heart-echo
nography: normal carotid arteries
a, suspected paraneoplastic syndrome with hypercoagulation of blood;
dl), diabetes mellitus; elevated ESR 74 mm (Westergren method); heart-
ler sonography: normal carotid arteries
peruricemia, heart-echo: suspected diastolic relaxation disturbance,
cy to arterial hypotension, Doppler sonography: normal carotid arteries
ytosis, severely elevated ESR. Doppler sonography: bilateral medium-
tion, venous thrombosis of the legs, coronary heart disease, arterial
ancer, compensated renal insufficiency; heart-echo: normal findings
eterozygotic); arterial hypertension, chronic smoker; recurrent
ht leg, Doppler-sonography: normal
: patients 4, 6, 7, 9, 10: 5 patients
ients. 1, 3, 4, 5, 9, 10: 6 patients
ency: patients 5, 7: 2 patients
s patients 2, 3, 4, 5, 6, 9: 6 patients. Suspected diastolic relaxation
tient
mal carotid artery findings patients: 2, 3, 4, 5, 6, 7, 10: 7 patients; 1 patient
-sized carotid stenoses
sion, BRAO branch retinal artery occlusion, CWSs cotton-wool spots, RE right
Table 2 Three patients with combined CRVO and BRAO
Patient age Diagnoses of systemic diseases
(no. of patients)
11. A 64-year-old male Arterial hypertension (230/140 mmHg)
Heart echo: ventricular hypertrophy
12. A 48-year-old male Chronic smoker;
patient noticed an amaurosis
fugax attack 2 weeks earlier
Heart-echo:
Patent foramen ovale; arterial
hypertension;
Doppler sonography: normal carotid
arteries
13. A 33-year-old woman Taking hormones to become pregnant
(Clonifen Galen, woman 1 Tbl/day) for
8 months; chronic smoker; coagulation
disturbance due to increased factor VIII
activity; heart-echo: normal findings.
Cerebral MRT: normal findings
Mean age: 2 males and 1
female: 48.3 (33–64 years)
Arterial hypertension: patient 11
Chronic smoker: patients 12, 13
Hormone treatment: patient 13
Heart-echo: normal findings:
patient 13
Coagulation disturbance: patient 13
Patent foramen ovale: patient 12
Ventricular hypertrophy: patient 11
Doppler sonography: normal carotid
arteries: patient 12
Figure 2 A new episode with pronounced retinal changes:
papilledema, cotton-wool spots and additional hemorrhages
(2 weeks later with deterioration of retinal findings, patient no. 4).
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[16], Sullivan et al. [46]), thrombosis of the orbital super-
ior ophthalmic vein (Hsu et al. [21]), meningeal carci-
nomatosis with compression of the retrobulbar optic
nerve (Schaible & Golnik [40]).Figure 1 LE: Left Eye Initial stage of infarction of the inferior
temporal artery associated with a few dot-and-blot
hemorrhages and enlarged, tortuous veins in the left eye of a
62-year-old man (patient no. 4).Inflammatory ocular and/or orbital diseases of un-
known origin (Bender [6]), papillophlebitis (Cassen et al.
[9]) orbital inflammatory pseudotumor (Foroozan: [15]).
General diseases, immunological diseases.
Antiphospholipid syndrome (Ang et al. [4], Durukan
[14]).
Systemic lupus erythematosus (Brown et al. [8], Cobo-
Soriano et al. [11], Coppeto & Lessell [12]).
Churg-Strauss syndrome (Hamann [20]), Behçet’s dis-
ease (Richards [37]), interferon treatment (Jenisch et al.
[24]).
Vascular diseases.
Arterial hypertension (Brazitikos et al. [7], Brown et al.
[8], Limaye et al. [29], Vallé et al. [49], McLeod &
Ring [30]), diabetes mellitus (Arikan et al. [5], Brown
et al. [8]).Figure 3 LE: Infarction of a large cilioretinal artery associated
with a CRVO in the left eye of a 39-year-old male who had
arterial hypertension (patient no. 14).
Figure 4 RE: Right Eye in a 57-year-old woman. Swelling of the
optic disk, macular edema, macular cherry-red spot and multiple
retinal hemorrhages (patient no. 10).
Figure 6 Fluorescein-angiogram: 1 min, 56 s after dye injection.
All vessels are filled with dye. Sludge phenomenon in superior
temporal veins (patient no. 10).
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Raynaud’s syndrome (Glacet-Bernard et al. [17]), smoker
(Vallé et al. [49]).
Oral contraceptives (Brazitikos et al. [7], Glacet-
Bernard et al. [17]), syphilis (Smith [44]).
Coagulopathy.
Activated protein C resistance (Vallé et al. [49]).
Inflammatory disease.
Sinus thrombosis.Figure 5 Fluorescein-angiogram: 48 s after dye injection:
delayed filling of vessels, tortuosity of vessels mainly in the
area of the posterior pole, some peripheral vessels are not
filled with fluorescein (temporal superior and nasal inferior
areas) (patient no. 10).Sinusitis and thrombosis in the sinus cavernosus
(Richards: [37]).
Malignancies.
Prostate cancer (Jorizzo: [25]).
Non-Hodgkin’s lymphoma (Guyer et al. [19], Saatci
[39]).
Lymphocytic leukemia (Chan et al. [10], Richards
[37]).
In the ten patients with visual loss (Table 1), the right
eye was affected in six and the left eye in four. For the ex-
aminations, fluorescein angiography was carried out in
eight patients, revealing delayed arterial filling in six
(patients 1, 2, 3, 4, 5, 10) and no filling delay in two
(patients 7, 8). Optic disk swelling was observed in five pa-
tients (nos. 2, 3, 4, 8, 10); cotton-wool spots (CWSs) were
detected in two patients (nos. 2 and 6).
Five patients (nos. 2, 3, 5, 7, 8) experienced distinct
visual improvement after treatment, one patient (no. 6) a
slight improvement, three patients (nos. 1, 9, 10) no vis-
ual change and one patient (no. 4) a slight deterioration.
In the three patients with visual loss (Table 2), the
right eye was affected (nos. 11, 12, 13). All three un-
derwent fluorescein-angiography, which revealed delayed
arterial filling in one patient. We observed distinct
visual improvement after treatment in one patient
(no. 12) and no change in visual acuity in two pa-
tients (nos. 11 and 13).
In one patient with CLRAO and CRVO (no. 14), the
left eye was affected. Fluorescein angiography revealed
delayed dye filling of the cilioretinal artery. His visual
acuity improved after treatment.
Doppler sonography was carried out in ten patients;
nine had normal carotid arteries. Only one patient dem-
onstrated bilateral, moderately sized carotid stenoses.
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ding normal findings in 8 (nos. 2, 3, 4, 5, 6, 9, 13, 14).
One patient (no. 7) was suspected of having a diastolic
disturbance during myocardial relaxation, while another
patient (no. 11) presented ventricular hypertrophy. Ano-
ther patient (no. 12) revealed a patent foramen ovale.
The 48-year-old male with the patent foramen ovale had
arterial hypertension and was a chronic smoker (as co-
morbidity).
Treatment in some patients consisted of isovolemic
hemodilution, aspirin administration or other anticoagu-
lants. One patient received corticosteroids (no. 1). In
those with systemic diseases, treatment was carried out
in cooperation with internists. In one patient (no. 1,
Table 1) with combined CRVO and CRAO, vitrectomy
and endolaser treatment of the retina were carried out.
One patient (no. 14, Table 3) revealed a combined CRVO
with a cilioretinal arterial occlusion (CLRAO). This 39-
year-old male was diagnosed with increased diastolic
blood pressure. His visual acuity was 20/400 initially, im-
proving slightly to 20/200 after anticoagulant treatment
and lowering his blood pressure.
After treatment, we noted a distinct improvement in
visual acuity (more than two lines) in six patients (nos.
2, 3, 5, 7, 8, 12), slight improvement in one patient (no. 6),
no change in visual acuity in five patients (nos. 1, 9, 10,
11, 13, 14) and deterioration in one patient after a recur-
rence (no. 4).
The patients whose visual acuity improved subs-
tantially were those with BRAO and incomplete CRVO,
autoimmune disease (no. 5), hyperhomocysteinemia
(no. 7), hypertension (nos. 3, 12) and bronchopneu-
monia (nos. 2, 8).
Results
Eight patients were diagnosed with arterial hypertension,
three with hypercholesterolemia and six with coagula-
tion anomalies. Three patients were chronic smokers.
Eleven of our 14 patients presented comorbidities in the
form of several cardiovascular risk factors.
Comorbidities were striking in our patients, as at least
11 of them presented several diseases, i.e., immunocy-
toma and arterial hypertension in conjunction with hy-
percholesterolemia (patient 1); chronic bronchitis with
tachycardia and hypercholesterolemia (patient 2); arterialTable 3 A patient with combined cilioretinal artery
occlusion (CLRAO) and CRVO
Patient age Diagnoses of systemic diseases
(no. of patients)
14. A 39-year-old male Arterial hypertension;
Doppler sonography: normal carotid arteries
Heart echo: normal findingshypertension and hypercholesterolemia (patient 3); auto-
immune disease with evidence of serum antimitochon-
drial antibodies and a tendency to arterial hypotension
(patient 5); prostate cancer, anemia, a coagulation ano-
maly and diabetes mellitus (patient 6); hyperhomo-
cysteinemia, hyperuricemia and a suspected diastolic
disturbance of cardiac relaxation (patient 7); broncho-
pneumonia and a bilateral, medium-sized carotid
stenosis (patient 8); heterozygous factor V mutation
associated with venous thrombosis of the leg and arterial
hypertension (patients 9 and 10); chronic smoking habit
and a patent foramen ovale (patient 12); chronic smoker
and a coagulation disorder (patient 13).
The three remaining (nos. 4, 11 and 14) presented less
serious comorbidities: patient 4 had slightly elevated
blood pressure and slightly increased homocysteine,
patient 11 suffered from extremely high blood pres-
sure, and patient 14 (who had an occlusion of a large
cilioretinal artery) suffered from arterial hypertension.
We identified no additional risk factors in these three
patients.
Six patients presented coagulation anomalies in con-
junction with other cardiovascular diseases, for instance
the patient with paraneoplastic syndrome and diabetes
mellitus. Arterial hypertension was diagnosed in 8 of 14
patients. One patient (no. 12) revealed a patent foramen
ovale and hypertension. We detected no emboli in any
of the patients ophthalmoscopically.Discussion
Concerning the risk profile, the cardiovascular risk fac-
tors for retinal artery occlusion are arterial hypertension,
carotid artery diseases, cardiac rhythm disorders and
cardiac valvular diseases, diabetes mellitus, hyperlipid-
emia, hyperuricemia and chronic smoking [3]. The cause
of retinal artery occlusions in most patients is embolic.
In our patients with combined CRAO with CRVO, how-
ever, no emboli were detected.
The main ophthalmoscopic feature of this entity is the
absence of an embolus. Carotid artery examination and
echocardiography in most of our patients failed to reveal
cardiovascular anomalies that could lead to emboli. We
carried out Doppler sonography in nine patients, of
whom eight had normal carotid arteries. Only one pa-
tient revealed a moderate bilateral carotid stenosis.
Brown et al. [8] also reported the absence of carotid
stenosis in most of their patients. Echocardiography was
carried out in 11 patients in our group. Eight of them re-
vealed no abnormalities, and only one patient, a chronic
smoker, presented a patent foramen ovale (no. 12). Ano-
ther patient revealed ventricular hypertrophy (no. 11),
and a diastolic relaxation disturbance was suspected in
an additional patient (no. 7).
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hypertension, diabetes mellitus and open-angle glau-
coma [1]. In patients with combined CRAO with CRVO,
however, the risk profile seems to differ because a com-
bination of cardiovascular risk factors is essential in this
entity. Eleven of our 14 patients presented comorbidities
in the form of several cardiovascular risk factors.
The literature describes several systemic diseases, some
of which were detected in our patients, that can cause this
vascular entity, i.e., coagulation disturbances, arterial hy-
pertension, arteriosclerosis, mechanical vessel comp-
ression at the optic nerve level, vascular inflammation,
immunological diseases, systemic lupus erythematosus,
Behçet’s disease, non-Hodgkin’s lymphoma and interferon
therapy.
Comorbidities are also described in some patients in the
literature. Vallée et al. [49] reported on 1 of 11 patients
who suffered from hypertension, anticardiolipin syndrome
and von Willebrand syndrome. Another patient revealed
hypercholesterolemia and protein S deficiency. In an add-
itional patient who smoked, hypertension and monoclonal
gammopathy were diagnosed.
Glacet-Bernard et al. [17] described one of seven pa-
tients who was a chronic smoker and presented hyper-
tension as well as hypercholesterolemia, hyperuricemia
and hyperfibrinogenemia.
A 62-year-old patient suffered from prostate cancer
and diabetes mellitus [25]. Leibovitch et al. [27] diag-
nosed systemic lupus erythematosus with lupus nephritis
and severe hypertension in a 23-year-old man.
We assume that combined CRAO and CRVO occur
simultaneously or within a short interval. However, an
exception to this was published by Ang et al. [4]: a pa-
tient with an antiphospholipid syndrome initially re-
vealed a CRVO and 1 month later an ophthalmic artery
occlusion. Rachitskaya et al. [36] reported a CRVO in a
50-year-old man who presented a CRAO 2 weeks later.
Total bilateral blindness in conjunction with a com-
plete arterial and venous interruption in blood flow was
described by Coppeto & Lessell [12]. They reported se-
vere bilateral retinal vasculitis with total retinal circu-
lation arrest from thrombosis in most of the retinal
vessels, including major arterioles, due to lupus erythe-
matosus. That patient’s history also differed from our pa-
tients’ medical histories. Bilateral visual deterioration or
blindness has also been reported [5,6,19].
We diagnosed a combined occlusion of a cilioretinal
artery (CLRAO) with a CRVO in one patient (no. 14).
Schatz et al. [41] observed ten patients presenting this
combined occlusion. Schatz et al. noted pulsations in the
cilioretinal artery in five eyes. They emphasized that the
cilioretinal artery occlusion was not embolic. Due to
lower perfusion pressure, the cilioretinal artery becomes
relatively occluded. Their ten patients, all under 50 yearsof age, revealed cilioretinal artery occlusion associated
with a non-ischemic CRVO. This disease’s prognosis is
generally good. Eight of those nine eyes demonstrated a
final visual acuity of 20/30 or better.
The prognosis of combined CRAO and CRVO, even if
incomplete, is very poor, including blindness if left un-
treated. Such combined vascular retinal occlusions are
caused by systemic diseases that should be treated at an
early stage by an ophthalmologist and internist working
together. As the systemic diseases in our patients are
fundamental, treatment should be carried out in coope-
ration with internists.
Vallée et al. [49] are the only authors who treated pa-
tients with combined CRAO and CRVO via fibrinolysis.
They selectively perfused urokinase via the femoral artery
into the ophthalmic artery. Seven of eleven of their pa-
tients’ vision improved substantially, while one revealed
an intravitreal hemorrhage with visual deterioration.
Patients with a combined retinal arteriovenous occlu-
sion should be carefully followed up over months or
years because of threatening neovascularization glau-
coma. Rubeosis iridis was observed by Brown et al. [8],
Smith [44], Stowe et al. [45], Richards [37], Sullivan
et al. [46], Duker et al. [13] and Rachitskaya et al. [36].
Brown et al. [8] observed rubeosis iridis in 17 out of
21 patients (81%) with at least 6-month follow-up.
Conclusions
The essential findings in our 14 patients were:
1) Unilateral simultaneous combined incomplete retinal
artery and vein occlusions should be considered as
one entity,
2) Eleven patients (78.6%) revealed co-morbidities
presenting as cardiovascular risk factors such as
arterial hypertension, hypercholesterolemia and
chronic smoking. Immunological diseases,
malignancies and coagulopathies may lead to this
ocular disorder, causing blindness.
3) Normal echocardiography in eight patients and
normal Doppler sonography findings in nine patients
were revealed.
4) The mean age was 57.6 years (33–75).
5) None of our patients presented an embolism. This is
therefore the main difference from an isolated CRAO
or BRAO, as they often are caused by embolic events.
6) Patients suffering from acute visual loss must be
examined for the presence of a systemic disease to
enable treatment at an early stage.
Consent
Written informed consent was obtained from the patient
for the publication of this report and any accompanying
images.
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